Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN99,2499,5-0,17
Msft0,70
Nokia5,6845,802-1,75
IBM2,59
Mercedes-Benz Group AG58,8558,87-0,88
PFE-0,93
17.01.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 16.01.2026 17:36:35
Gerresheimer (GXIG.DE, Xetra)
Závěr k 16.1.2026 Změna (%) Změna (EUR) Objem obchodů (EUR)
25,36 -3,21 -0,84 4 585 699
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 18.01.2026
Popis společnosti
Obecné informace
Název společnostiGerresheimer AG
TickerGXI
Kmenové akcie:Ordinary Shares
RICGXIG.DE
ISINDE000A0LD6E6
Poslední známé roční výsledky30.11.2024
Poslední známé čtvrtletní výsledky31.08.2025
Počet zaměstnanců k 31.08.2025 13 535
Akcie v oběhu k 31.08.2025 34 540 000
MěnaEUR
Kontaktní informace
UliceKlaus-Bungert-Strasse 4
MěstoDUESSELDORF
PSČ40468
ZeměGermany
Kontatní osobaGuido Pickert
Funkce kontaktní osobyVice President - Corporate Investor Relations
Telefon49 211 618 100
Fax492116181295
Kontatní telefon492 116 181 220

Business Summary: Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.
Financial Summary: BRIEF: For the nine months ended 31 August 2025, Gerresheimer AG revenues increased 15% to EUR1.68B. Net loss totaled EUR13.7M vs. income of EUR72.7M. Revenues reflect Plastics & Devices segment increase of 19% to EUR972.6M, Primary Packaging Glass segment increase of 10% to EUR714.4M. Net loss reflects other operating expenses increase from EUR20.1M to EUR68.1M (expense).
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYFabricated Plastic & Rubber
MGSECTORBasic Materials
NAICSAll Other Plastics Product Manufacturing
NAICSGlass Container Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
NAICSAnalytical Laboratory Instrument Manufacturing
NAICSOffices of Other Holding Companies
NAICS2007All Other Plastics Product Mfg
NAICS2007Glass Container Mfg
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Surgical Appliance & Supplies Mfg
NAICS2007Analytical Laboratory Instrument Mfg
NAICS2007Offices of Other Holding Companies
NAICS1997All Other Plastics Product Manufacturing
NAICS1997Glass Container Manufacturing
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Surgical Appliance and Supplies Manufacturing
NAICS1997Analytical Laboratory Instrument Manufacturing
NAICS1997Offices of Other Holding Companies
SICPlastics Products, Nec
SICGlass Containers
SICSurgical And Medical Instruments
SICAnalytical Instruments
SICHolding Companies, Nec



  • Poslední aktualizace: 18.01.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Independent Chairman of the Supervisory BoardAxel Herberg6730.04.201501.01.1996
Interim Chief Executive Officer, Member of the Management BoardUwe Roehrhoff6001.11.202501.01.2003
Deputy Chairman of the Supervisory BoardMarkus Roemer5917.12.202417.12.2024
Chief Financial Officer, Member of the Management BoardWolf Lehmann-01.09.202501.09.2025
Member of the Management BoardAchim Schalk-01.11.202501.11.2025